120 related articles for article (PubMed ID: 7947790)
1. Three-dimensional structure of chymotrypsin inactivated with (2S)-N-acetyl-L-alanyl-L-phenylalanyl alpha-chloroethane: implications for the mechanism of inactivation of serine proteases by chloroketones.
Kreutter K; Steinmetz AC; Liang TC; Prorok M; Abeles RH; Ringe D
Biochemistry; 1994 Nov; 33(46):13792-800. PubMed ID: 7947790
[TBL] [Abstract][Full Text] [Related]
2. Chloroketone hydrolysis by chymotrypsin and N-methylhistidyl-57-chymotrypsin: implications for the mechanism of chymotrypsin inactivation by chloroketones.
Prorok M; Albeck A; Foxman BM; Abeles RH
Biochemistry; 1994 Aug; 33(32):9784-90. PubMed ID: 8068658
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of delta-chymotrypsin bound to a peptidyl chloromethyl ketone inhibitor.
Mac Sweeney A; Birrane G; Walsh MA; O'Connell T; Malthouse JP; Higgins TM
Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):280-6. PubMed ID: 10713514
[TBL] [Abstract][Full Text] [Related]
4. 15N and 1H NMR spectroscopy of the catalytic histidine in chloromethyl ketone-inhibited complexes of serine proteases.
Tsilikounas E; Rao T; Gutheil WG; Bachovchin WW
Biochemistry; 1996 Feb; 35(7):2437-44. PubMed ID: 8652587
[TBL] [Abstract][Full Text] [Related]
5. Site-selective chemical modification of chymotrypsin using peptidyl derivatives bearing optically active diphenyl 1-amino-2-phenylethylphosphonate: Stereochemical effect of the diphenyl phosphonate moiety.
Ono S; Nakai T; Kuroda H; Miyatake R; Horino Y; Abe H; Umezaki M; Oyama H
Biopolymers; 2016 Nov; 106(4):521-30. PubMed ID: 26615968
[TBL] [Abstract][Full Text] [Related]
6. Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors.
Brady K; Wei AZ; Ringe D; Abeles RH
Biochemistry; 1990 Aug; 29(33):7600-7. PubMed ID: 2271520
[TBL] [Abstract][Full Text] [Related]
7. A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond.
Cassidy CS; Lin J; Frey PA
Biochemistry; 1997 Apr; 36(15):4576-84. PubMed ID: 9109667
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of gamma-chymotrypsin in complex with 7-hydroxycoumarin.
Ghani U; Ng KK; Atta-ur-Rahman ; Choudhary MI; Ullah N; James MN
J Mol Biol; 2001 Nov; 314(3):519-25. PubMed ID: 11846564
[TBL] [Abstract][Full Text] [Related]
9. X-ray crystal structure of a dipeptide-chymotrypsin complex in an inhibitory interaction.
Kashima A; Inoue Y; Sugio S; Maeda I; Nose T; Shimohigashi Y
Eur J Biochem; 1998 Jul; 255(1):12-23. PubMed ID: 9692896
[TBL] [Abstract][Full Text] [Related]
10. O'-(epoxyalkyl)tyrosines and (epoxyalkyl)phenylalanine as irreversible inactivators of serine proteases: synthesis and inhibition mechanism.
Tous G; Bush A; Tous A; Jordan F
J Med Chem; 1990 Jun; 33(6):1620-34. PubMed ID: 2187995
[TBL] [Abstract][Full Text] [Related]
11. Correlations of the basicity of His 57 with transition state analogue binding, substrate reactivity, and the strength of the low-barrier hydrogen bond in chymotrypsin.
Lin J; Cassidy CS; Frey PA
Biochemistry; 1998 Aug; 37(34):11940-8. PubMed ID: 9718318
[TBL] [Abstract][Full Text] [Related]
12. Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes.
Stoll VS; Eger BT; Hynes RC; Martichonok V; Jones JB; Pai EF
Biochemistry; 1998 Jan; 37(2):451-62. PubMed ID: 9425066
[TBL] [Abstract][Full Text] [Related]
13. Complex of alpha-chymotrypsin and N-acetyl-L-leucyl-L-phenylalanyl trifluoromethyl ketone: structural studies with NMR spectroscopy.
Liang TC; Abeles RH
Biochemistry; 1987 Dec; 26(24):7603-8. PubMed ID: 3427096
[TBL] [Abstract][Full Text] [Related]
14. Detection of native peptides as potent inhibitors of enzymes. Crystal structure of the complex formed between treated bovine alpha-chymotrypsin and an autocatalytically produced fragment, IIe-Val-Asn-Gly-Glu-Glu-Ala-Val-Pro-Gly-Ser-Trp-Pro-Trp, at 2.2 angstroms resolution.
Singh N; Jabeen T; Sharma S; Roy I; Gupta MN; Bilgrami S; Somvanshi RK; Dey S; Perbandt M; Betzel C; Srinivasan A; Singh TP
FEBS J; 2005 Jan; 272(2):562-72. PubMed ID: 15654893
[TBL] [Abstract][Full Text] [Related]
15. The role of N-terminal heterocycles in hydrogen bonding to α-chymotrypsin.
Schumann NC; Bruning J; Marshall AC; Abell AD
Bioorg Med Chem Lett; 2019 Feb; 29(3):396-399. PubMed ID: 30579793
[TBL] [Abstract][Full Text] [Related]
16. Design of serine protease inhibitors with conformation restricted by amino acid side-chain-side-chain CH/pie interaction.
Shimohigashi Y; Nose T; Yamauchi Y; Maeda I
Biopolymers; 1999; 51(1):9-17. PubMed ID: 10380349
[TBL] [Abstract][Full Text] [Related]
17. Potent inactivator of alpha-chymotrypsin: 2,2-dimethyl-3-(N-4-cyanobenzoyl)amino-5-phenyl pentanoic anhydride.
Ito K; Igarashi K; Muramatsu M; Harada T; Hayashi Y; Katada J; Uno I
Biochem Biophys Res Commun; 1997 Nov; 240(3):850-5. PubMed ID: 9398657
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of alpha-lytic protease complexes with irreversibly bound phosphonate esters.
Bone R; Sampson NS; Bartlett PA; Agard DA
Biochemistry; 1991 Feb; 30(8):2263-72. PubMed ID: 1998685
[TBL] [Abstract][Full Text] [Related]
19. Peptidyl inverse esters of p-methoxybenzoic acid: a novel class of potent inactivator of the serine proteases.
Lynas J; Walker B
Biochem J; 1997 Aug; 325 ( Pt 3)(Pt 3):609-16. PubMed ID: 9271079
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
